The page is the record's research on the issuer — no analyst, no rating, no view.

# Kura Oncology, Inc. (NASDAQ: KURA) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Kura Oncology, Inc., listed on NASDAQ under ticker KURA, with ISIN US50127T1097 and LEI 5493005QORQTZCZYOP39. Its security type is Corporate and its sector is 2834 Pharmaceutical Preparations. Its jurisdiction is United States, Delaware. Its segment is not on the record. Its status is listed, not halted.

## The disclosure read

The record holds 105 filings across 45 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 4.0 days, and the latest filing is dated 2026-10-27, 12 days before the record date, and is of type regulatory_filing. The NASDAQ median is 6.0 days for cadence, 52 filings and 5.0 days for latency across 4359 issuers. The 2834 Pharmaceutical Preparations sector median is 6.0 days for cadence, 63.0 filings and 4.0 days for latency across 526 issuers.

## Auditor

The auditor of record is Ernst & Young LLP, located in San Diego, CA USA. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable, as the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations page. The count is 0.

## Open research

No openly published research notes were found. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- https://data.sec.gov/submissions/CIK0001422143.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/KURA (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1422143/000119312526092567/kura-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/KURA (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/KURA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
